Ketamine Clinic Market Report 2025

The ketamine clinic market size has grown strongly in recent years. It will grow from $1.21 billion in 2024 to $1.32 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth during the historic period can be attributed to the increasing demand for alternative mental health treatments, the expansion of mental health treatment centers, growth in outpatient infusion clinics, a rise in out-of-pocket spending on mental health care, and improved affordability of generic ketamine.

The ketamine clinic market size is expected to see strong growth in the next few years. It will grow to $1.9 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth projected for the forecast period can be attributed to the increasing prevalence of treatment-resistant depression, rising cases of anxiety disorders, growing diagnoses of post-traumatic stress disorder, high rates of chronic pain conditions, and the expanding recognition of mental health disorders as chronic illnesses. Key trends during this period include the rise of telemedicine for ketamine-assisted therapy screening, the use of remote patient monitoring tools for post-infusion care, the development of mobile apps for mood tracking during ketamine treatment, integration of electronic medical records with ketamine therapy protocols, and the implementation of AI-enabled tools to identify suitable candidates for treatment.

The rising prevalence of mental health disorders is anticipated to drive the growth of the ketamine clinic market in the coming years. Mental health disorders involve disturbances in emotions, thinking, or behavior that can affect daily functioning and social relationships. One key contributor to the increase in mental health issues is growing social isolation, which leads to heightened emotional and psychological stress due to reduced human interaction and support. Ketamine clinics provide rapid-acting treatments that help alleviate symptoms of anxiety and depression, preventing these conditions from escalating into more severe mental health problems. For example, in June 2025, the Centers for Disease Control and Prevention, a US government agency, reported that between 2022 and 2023, 11% of children aged 3 to 17 were diagnosed with anxiety, 9% for boys and 12% for girls, while 8% had behavioral disorders, affecting 10% of boys and 5% of girls. Hence, the growing incidence of mental health conditions is propelling the ketamine clinic market forward.

Leading companies in the ketamine clinic market are concentrating on developing innovative solutions, such as evidence-based therapies, which rely on proven, systematic research and clinical studies to ensure consistent treatment outcomes. Evidence-based therapies are scientifically validated approaches used to address specific psychological or behavioral issues. For instance, in June 2025, Rooted Rhythm Therapy, a US mental health service provider, partnered with Noma Therapy, a US ketamine-assisted psychotherapy provider, to launch an insurance-covered ketamine therapy program. This initiative combines expert somatic care with professional psychotherapy tailored specifically for parents facing depression, anxiety, burnout, or trauma. The program integrates ketamine-assisted therapy from Noma, clinical guidance, and Rooted Rhythm’s parent-centered educational and emotional support. Services include ketamine treatment covered by insurance, along with professional dosing and medication management, as well as individual and group therapy focused on emotional regulation, somatic techniques, and family-friendly scheduling.

In February 2024, Ketamine Wellness Clinic of Orange County, a US-based ketamine therapy provider, acquired Mind Space Ketamine Infusion Clinic for an undisclosed sum. This acquisition expands the combined clinics' treatment offerings for mood and pain-related conditions. It also aims to enhance patient care across Laguna Beach and the wider Orange County region by introducing more advanced ketamine therapy methods. Mind Space Ketamine Infusion Clinic is a US-based ketamine treatment provider.

Major players in the ketamine clinic market are Mindbloom Inc., Mindful Health Solutions, Neuro Wellness Spa, The Ketamine Clinic, Clarity Clinic, Revitalist Lifestyle and Wellness Ltd., Nushama, Innerwell, Klarisana Health, NY Ketamine Infusions, Axon Therapies Inc., Alleviant Health Centers, Lone Peak Psychiatry, MindPeace Clinics, NeuroRelief Ketamine & Infusion Therapy, Choose Your Horizon Inc., Innerbloom Ketamine Therapy, Viking Psychiatry, Norcal Ketamine Infusion Centers, and Pacific KLN Infusions.

North America was the largest region in the ketamine clinic market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in ketamine clinic report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the ketamine clinic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ketamine clinic market includes revenues earned by entities by administration services, pre- and post-session support, progress tracking, and vital sign monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The ketamine clinic market research report is one of a series of new reports that provides ketamine clinic market statistics, including ketamine clinic industry global market size, regional shares, competitors with a ketamine clinic market share, detailed ketamine clinic market segments, market trends and opportunities, and any further data you may need to thrive in the ketamine clinic industry. This ketamine clinic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A ketamine clinic is a specialized healthcare facility focused on administering and overseeing ketamine treatments in a controlled, professional environment. These clinics are staffed by licensed medical professionals and follow strict regulatory and safety protocols. They provide a secure setting to ensure accurate dosing, patient monitoring, and effective risk management.

The primary therapy options at ketamine clinics include online therapy and on-site therapy. Online therapy utilizes digital platforms to offer mental health support via video calls, chat, or virtual consultations. This approach treats conditions such as anxiety, depression, post-traumatic stress disorder (PTSD), and more, drawing referrals from primary care physicians, online marketing, and mental health specialists. Ketamine administration methods include injectable forms, nasal sprays, and oral tablets. The treatment serves various end users, including individuals, hospitals and clinics, specialized ketamine centers, and research institutions.

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.